Transforming 300 billion points of data into diagnostics, therapeutics and new insights into disease

Abstract

INTRODUCTION Over the past few years, collaboration between the CPNP Research and Program Committees has resulted in high quality, member-driven research programming at the Annual Meeting. Programming input is requested from all CPNP committees but this collaboration, in particular, has led to the development of focused programming fulfilling a need for members who either work primarily in a research setting or want to keep abreast of the everchanging field of psychopharmacology research. One of the logistical difficulties of this type of collaboration is the CPNP programming timeline. It is not long after the Annual Meeting that the following year's offerings are determined. With the focus of both committees and commitment to excellence in programming, this project has been a great success. The collaboration has led to two-hour tracks of programming ranging from 'Incorporating Health Services Research into Practice' to this past meeting's 'Academic Detailing'. An additional hour of research programming this year focused on drug repurposing/repositioning. Dr. Atul Butte, MD, a bioinformatician and pediatric endocrinologist from Stanford University's School of Medicine, whose lab uses publicly available molecular measurements to find new uses for drugs, presented a lecture entitled, "Transforming 300 Billion Points of Data into Diagnostics, Therapeutics and New Insights into Disease". As the offerings are many at the Annual Meeting, CPNP Program Committee leadership thought a brief review of what was discussed in this lecture was in order for all members.